Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Venture Capital
Biotech
Sparrow flits forward with $95M for midstage diabetes asset
The Oregon biotech will use the raise for a phase 2b trial of oral small molecule clofutriben in patients with Type 2 diabetes and excess cortisol.
Darren Incorvaia
Sep 24, 2025 11:22am
Fierce Biotech Fundraising Tracker: Avenzo, Sparrow & more
Sep 24, 2025 11:00am
Sanofi juices up venture arm with $625M infusion
Sep 24, 2025 1:00am
Big Pharma-backed MapLight plots IPO
Sep 22, 2025 1:57pm
Biotech veteran Robert Langer joins son launching new VC
Sep 18, 2025 3:15pm
US VC launches another biotech with China-licensed asset
Sep 17, 2025 10:30am
